UniProt ID | RPAC1_HUMAN | |
---|---|---|
UniProt AC | O15160 | |
Protein Name | DNA-directed RNA polymerases I and III subunit RPAC1 | |
Gene Name | POLR1C | |
Organism | Homo sapiens (Human). | |
Sequence Length | 346 | |
Subcellular Localization | Nucleus . | |
Protein Description | DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I and III which synthesize ribosomal RNA precursors and small RNAs, such as 5S rRNA and tRNAs, respectively. RPAC1 is part of the Pol core element with the central large cleft and probably a clamp element that moves to open and close the cleft (By similarity).. | |
Protein Sequence | MAASQAVEEMRSRVVLGEFGVRNVHTTDFPGNYSGYDDAWDQDRFEKNFRVDVVHMDENSLEFDMVGIDAAIANAFRRILLAEVPTMAVEKVLVYNNTSIVQDEILAHRLGLIPIHADPRLFEYRNQGDEEGTEIDTLQFRLQVRCTRNPHAAKDSSDPNELYVNHKVYTRHMTWIPLGNQADLFPEGTIRPVHDDILIAQLRPGQEIDLLMHCVKGIGKDHAKFSPVATASYRLLPDITLLEPVEGEAAEELSRCFSPGVIEVQEVQGKKVARVANPRLDTFSREIFRNEKLKKVVRLARVRDHYIFSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAASQAVEE ------CCHHHHHHH | 18.80 | 22223895 | |
4 | Phosphorylation | ----MAASQAVEEMR ----CCHHHHHHHHH | 14.77 | 23663014 | |
33 | Phosphorylation | TTDFPGNYSGYDDAW CCCCCCCCCCCCCCC | 14.91 | 28796482 | |
33 (in isoform 2) | Phosphorylation | - | 14.91 | - | |
34 | Phosphorylation | TDFPGNYSGYDDAWD CCCCCCCCCCCCCCC | 34.57 | 28796482 | |
36 | Phosphorylation | FPGNYSGYDDAWDQD CCCCCCCCCCCCCHH | 12.52 | 28796482 | |
47 | Ubiquitination | WDQDRFEKNFRVDVV CCHHHHHHCCCEEEE | 59.69 | 21906983 | |
47 (in isoform 2) | Ubiquitination | - | 59.69 | 21890473 | |
47 (in isoform 1) | Ubiquitination | - | 59.69 | 21890473 | |
86 | Phosphorylation | ILLAEVPTMAVEKVL HHHHCCCCEEEEEEE | 23.96 | 29396449 | |
91 | Ubiquitination | VPTMAVEKVLVYNNT CCCEEEEEEEEECCC | 33.98 | - | |
95 | Phosphorylation | AVEKVLVYNNTSIVQ EEEEEEEECCCHHHH | 9.87 | 28152594 | |
98 | Phosphorylation | KVLVYNNTSIVQDEI EEEEECCCHHHHHHH | 19.05 | 28152594 | |
99 | Phosphorylation | VLVYNNTSIVQDEIL EEEECCCHHHHHHHH | 23.92 | 28152594 | |
120 | Methylation | IPIHADPRLFEYRNQ CCCCCCHHHHCCCCC | 53.18 | 115491513 | |
124 | Phosphorylation | ADPRLFEYRNQGDEE CCHHHHCCCCCCCCC | 13.92 | 22817900 | |
125 | Methylation | DPRLFEYRNQGDEEG CHHHHCCCCCCCCCC | 23.07 | 115491507 | |
154 | Ubiquitination | TRNPHAAKDSSDPNE CCCCCCCCCCCCCCC | 59.95 | 21906983 | |
154 (in isoform 1) | Ubiquitination | - | 59.95 | 21890473 | |
154 (in isoform 2) | Ubiquitination | - | 59.95 | 21890473 | |
157 | Phosphorylation | PHAAKDSSDPNELYV CCCCCCCCCCCCEEE | 68.19 | 25159151 | |
163 | Phosphorylation | SSDPNELYVNHKVYT CCCCCCEEECCEEEE | 7.94 | 28152594 | |
167 | Ubiquitination | NELYVNHKVYTRHMT CCEEECCEEEECEEE | 31.56 | 21906983 | |
167 (in isoform 2) | Ubiquitination | - | 31.56 | 21890473 | |
167 | Acetylation | NELYVNHKVYTRHMT CCEEECCEEEECEEE | 31.56 | 23236377 | |
167 (in isoform 1) | Ubiquitination | - | 31.56 | 21890473 | |
169 | Phosphorylation | LYVNHKVYTRHMTWI EEECCEEEECEEEEE | 11.67 | 28152594 | |
170 | Phosphorylation | YVNHKVYTRHMTWIP EECCEEEECEEEEEE | 19.65 | 28152594 | |
220 | Ubiquitination | HCVKGIGKDHAKFSP HHHHCCCCCCCCCCC | 44.41 | 22817900 | |
224 (in isoform 2) | Ubiquitination | - | 42.85 | 21890473 | |
224 | Acetylation | GIGKDHAKFSPVATA CCCCCCCCCCCCCCE | 42.85 | 26051181 | |
224 (in isoform 1) | Ubiquitination | - | 42.85 | 21890473 | |
224 | Ubiquitination | GIGKDHAKFSPVATA CCCCCCCCCCCCCCE | 42.85 | 27667366 | |
226 | Phosphorylation | GKDHAKFSPVATASY CCCCCCCCCCCCEEE | 20.12 | 20068231 | |
226 (in isoform 2) | Phosphorylation | - | 20.12 | - | |
230 | Phosphorylation | AKFSPVATASYRLLP CCCCCCCCEEEEECC | 19.17 | 21406692 | |
232 | Phosphorylation | FSPVATASYRLLPDI CCCCCCEEEEECCCC | 13.36 | 21406692 | |
233 | Phosphorylation | SPVATASYRLLPDIT CCCCCEEEEECCCCE | 11.65 | 21406692 | |
240 | Phosphorylation | YRLLPDITLLEPVEG EEECCCCEEEECCCC | 32.44 | 20068231 | |
254 (in isoform 2) | Phosphorylation | - | 30.22 | - | |
254 | Phosphorylation | GEAAEELSRCFSPGV CHHHHHHHHHCCCCE | 30.22 | 20068231 | |
258 | Phosphorylation | EELSRCFSPGVIEVQ HHHHHHCCCCEEEEE | 25.11 | 21815630 | |
270 | Ubiquitination | EVQEVQGKKVARVAN EEEEECCEEEEEECC | 27.30 | 21963094 | |
270 | Acetylation | EVQEVQGKKVARVAN EEEEECCEEEEEECC | 27.30 | 26051181 | |
271 | Ubiquitination | VQEVQGKKVARVANP EEEECCEEEEEECCC | 48.20 | 22817900 | |
282 | Phosphorylation | VANPRLDTFSREIFR ECCCCCCHHHHHHHC | 28.27 | 21815630 | |
284 | Phosphorylation | NPRLDTFSREIFRNE CCCCCHHHHHHHCCH | 30.97 | 22817900 | |
294 | Ubiquitination | IFRNEKLKKVVRLAR HHCCHHHHHHHHHHH | 55.37 | 24816145 | |
332 | Ubiquitination | AIKVLMGKCRRFLDE HHHHHHHHHHHHHHH | 15.59 | 29967540 | |
332 | 2-Hydroxyisobutyrylation | AIKVLMGKCRRFLDE HHHHHHHHHHHHHHH | 15.59 | - | |
345 | Sulfoxidation | DELDAVQMD------ HHHHHHCCC------ | 5.47 | 21406390 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RPAC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RPAC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RPAC1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
248390 | Treacher Collins syndrome 3 (TCS3) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-33, AND MASSSPECTROMETRY. |